Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06409130
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-05-07
Brief Title:
Effects of NNC0194-0499 Cagrilintide and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Organization Data
Organization:
Novo Nordisk AS
Class:
INDUSTRY
Study ID:
NN9500-7730
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novo Nordisk AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None